SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Tocagen Inc. (TOCA)

TOCA RSS Feed
Add TOCA Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 11/17/2017 10:58:28 PM - Followers: 2 - Board type: Free - Posts Today: 0

Tocagen Inc. 3030 Bunker Hill Street Suite 230 San Diego, CA 92109 United States 858-412-8400 http://www.tocagen.com Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells. The company's lead product candidate is Toca 511 & Toca FC that is in Phase 2 portion of a randomized, controlled Phase 2/3 clinical trial for patients with recurrent high grade glioma (HGG). It is also developing Toca 511 & Toca FC in a Phase 1b clinical trial for metastatic cancers, including colorectal, pancreatic, breast, lung, melanoma, and renal. In addition, the company is developing other RRVs to deliver genes to cancer cells against validated immunotherapy targets, such as the checkpoint protein PD-L1. Tocagen Inc. was founded in 2007 and is headquartered in San Diego, California.
SureTrader
Interactive Brokers Advertisement
TOCA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TOCA News: Tocagen Announces Time Change for Presentation at Evercore ISI Biopharma Catalyst/Deep Dive Conference 11/21/2017 04:05:00 PM
TOCA News: Tocagen to Present at Two Investor Conferences in November 11/10/2017 08:00:00 AM
TOCA News: Tocagen to Present Updated Clinical and Preclinical Data at Three Scientific Conferences 11/09/2017 08:00:00 AM
TOCA News: Quarterly Report (10-q) 11/08/2017 05:29:51 PM
TOCA News: Current Report Filing (8-k) 11/08/2017 04:23:04 PM
PostSubject
#10   Great videos. Well done on the testimonials: gr8db8 11/17/17 10:58:28 PM
#9   nm gr8db8 11/17/17 10:58:27 PM
#8   Stifel summary gr8db8 11/15/17 07:35:21 PM
#7   The median survival in this trial is nearly gr8db8 11/04/17 09:14:52 PM
#6   TOCA 5 CLINICAL TRIAL gr8db8 11/04/17 09:10:50 PM
#5   Q3 2017 Earnings Release Wednesday, November 8, 2017 gr8db8 11/04/17 04:20:02 PM
#4   Durable responses observed in recurrent high-grade glioma (rHGG) gr8db8 11/04/17 04:14:22 PM
#3   More than a quarter of patients with a gr8db8 11/04/17 04:03:38 PM
#2   Investigators said once inside the cancer cell, the gr8db8 11/04/17 04:00:18 PM
#1   TOCA buy 15.90 stocktrademan 05/24/17 12:28:52 PM
PostSubject